SC
MBII

Savant Capital’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Savant Capital’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,067
Closed -$14K – 278
2017
Q2 		$14K Hold
11,067
– – ﹤0.01% 266
2017
Q1 		$22K Hold
11,067
– – 0.01% 261
2016
Q4 		$24K Buy
+11,067
New +$23.1K 0.01% 257

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Azimuth Capital Management Bloomfield Hills, Michigan $2.34B AUM 16.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Savant Capital's MBII Position: Q3 2017 in Review

Savant Capital sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2017, closing a stake of 11,067 shares — an estimated $14K sold.

Savant Capital first reported a position in MBII in Q4 2016 and held it in 3 quarters. The position peaked at $24K in Q4 2016. 23 funds tracked by Wall St. Rank hold MBII as of Q3 2017.

  • Savant Capital reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2017 after selling out during the quarter.
  • Savant Capital sold 11,067 Marrone Bio Innovations, Inc. shares in Q3 2017, an estimated $14K.
  • Savant Capital first reported a position in Marrone Bio Innovations, Inc. in Q4 2016 and held it in 3 quarters.
  • Savant Capital's Marrone Bio Innovations, Inc. position peaked at $24K in Q4 2016.
  • 23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2017.

Based on Savant Capital's 13F filing for Q3 2017, filed 31 Oct 2017.